**Question:** Virchow's node is seen in -

A. Lymph nodes in the spleen
B. Lymph nodes in the liver
C. Lymph nodes in the lungs
D. Lymph nodes in the skin

**Core Concept:** Virchow's triad is a set of three key factors that contribute to the development of chronic lymphatic leukemia (CLL), a type of blood cancer. These factors are:

1. Chronic inflammation (hyperplasia or hypertrophy) of lymphatic tissue, which results in the proliferation of lymphocytes, especially B cells. This is represented by Virchow's node (the enlarged lymph node).
2. Long-standing portal hypertension and its consequences, such as splenomegaly (enlarged spleen) and liver cirrhosis. These conditions promote the extravasation (leakage) of blood cells into the surrounding tissues, including the liver and spleen.
3. Exposure to certain risk factors, such as hepatitis B and C virus infections, human immunodeficiency virus (HIV) infection, and certain medications (e.g., alkylating agents, corticosteroids, or methotrexate).

**Why the Correct Answer is Right:** Virchow's node refers to the enlargement of lymphatic tissue, particularly the lymph nodes, due to the proliferation of lymphocytes, particularly B cells, which is a result of chronic inflammation. In the context of Virchow's triad, the correct answer is B, as the enlarged lymph nodes represent the inflammation and proliferation within the lymphatic system.

**Why Each Wrong Option is Incorrect:**

A. Lymph nodes in the spleen (option A) are not a part of Virchow's triad or Virchow's node. Virchow's triad is specifically associated with the liver and spleen, not the lymphatic system.

C. Lymph nodes in the lungs (option C) are not typically involved in Virchow's triad or Virchow's node. The primary focus is on the liver, spleen, and lymphatic system.

D. Lymph nodes in the skin (option D) are not a focus of Virchow's triad or Virchow's node. The triad focuses on the liver, spleen, and lymphatic system, not the skin.

**Clinical Pearl:** Virchow's triad highlights the association between chronic inflammation, portal hypertension, and the development of blood cancer, specifically chronic lymphatic leukemia (CLL) and chronic myeloid leukemia (CML). Understanding Virchow's triad can help clinicians identify patients at higher risk for these cancers and initiate appropriate diagnostic and preventive measures.